Delivery Order SPE2DB22D3016-SPE2DB24FALC0
- Not listed
- This contract is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, a specialty pharmaceutical product, with a potential value of $7,169.56 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,220.94, is for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a medical product. The contract has an ultimate completion date of April 1, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, a specialty pharmaceutical product, with a potential value of $16,397.85. The contract has a completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization that provides a wide range of pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product GAMUNEX-C, a 40 gram/400 ml vial. The delivery order has a ceiling value of $14,427.24 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,253.45, is for the supply of 4,567,958,190 units of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of GAMUNEX-C 20 gram/200 ml vials, with a potential value of $21,508.68 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order and is not operating under any set-aside designation. The contract is part of a larger indefinite delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product. The award has a potential value of $4,809.12 and a completion date of March 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $55,852.80, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract....
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of GAMUNEX-C 20 gram/200 ml vials, with a completion date of February 16, 2024 and a potential value of $14,295.00. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will provide these specialty pharmaceutical products to support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 1 gram/10 ml vials, a pharmaceutical product, with a firm fixed price and a total ceiling value of $1,468.56. The contract has an ultimate completion date of July 31, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FALC0Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product, with a potential value of $4,485.35 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 2/1/24 |